Rise of Local Pharma Industry in Pakistan

57 posts

Strategy Meetings in Pharma Industry – Asrar Qureshi’s Blog Post #1126

Asrar Qureshi’s blog post critiques the repetitive nature of annual strategy retreats in the pharma industry, highlighting their ineffectiveness. He proposes transformative approaches, such as framing retreats around key questions, inviting diverse voices, and fostering cross-functional collaboration. The goal is to inspire genuine innovation and actionable strategies for future success.
Share
View Post
  • 5 min

Why Pakistan’s Pharmaceutical Exports Lag Behind and How to Fix It– Asrar Qureshi’s Blog Post #1124

Pakistan’s pharmaceutical exports are notably low despite having a robust industry, with challenges including inadequate investment in facilities, lack of international certifications, inconsistent compliance with quality standards, and insufficient market intelligence. Strategic reforms, including regulatory improvements and investment in workforce development, are essential for enhancing exports and achieving global competitiveness.
Share
View Post
  • 6 min

Formation of PharmEx Pakistan – Too Late, Too Little? – Asrar Qureshi’s Blog Post #1123

The Ministry of Commerce in Pakistan is launching PharmEx Pakistan to boost pharmaceutical exports, aiming to increase annual exports from $700 million to $3 billion. This public-private initiative, modeled after India’s Pharmexcil, seeks to enhance regulatory compliance and global visibility for Pakistani pharmaceuticals, while facing challenges in international competitiveness.
Share
View Post
  • 4 min

Pharmaceutical Marketing – Stuck in the Past – Asrar Qureshi’s Blog Post #1103

The blog post discusses the stagnation of pharmaceutical marketing due to reliance on outdated strategies, regulatory constraints, and risk aversion. It emphasizes the need for innovation through data-driven personalization, omnichannel engagement, and agile methodologies. A cultural shift toward collaboration and customer-centric approaches is essential for modernization and relevance in a changing landscape.
Share
View Post
  • 5 min

AI and Machine Learning in Pharmaceutical Drug Development – Asrar Qureshi’s Blog Post #1102

The blog post by Asrar Qureshi discusses the transformative impact of Artificial Intelligence (AI) and Machine Learning (ML) on the pharmaceutical industry. It highlights innovations in drug discovery, preclinical development, clinical trials, and manufacturing, emphasizing efficiency and personalized medicine. However, challenges like data privacy and regulatory uncertainty must be addressed.
Share
View Post
  • 5 min

Stressed to Death: When Work Becomes a Silent Killer – Asrar Qureshi’s Blog Post #1096

Asrar Qureshi’s blog post addresses the escalating crisis of workplace stress, particularly within the pharmaceutical industry, linking it to tragic outcomes like premature deaths. It advocates for personal, organizational, and policy-level solutions to combat the stress epidemic, emphasizing the need for a culture that prioritizes employee well-being over relentless productivity.
Share
View Post
  • 5 min

Influence of Gen AI on Pharmaceutical Marketing – Now and in Five Years – Asrar Qureshi’s Blog Post #1088

Asrar Qureshi’s blog discusses the transformative impact of Artificial Intelligence (AI) on pharmaceutical marketing, emphasizing its evolution towards more data-driven, personalized strategies. It highlights current capabilities, like AI in predictive analytics and content creation, while forecasting increased AI integration over the next five years, offering significant advantages to adaptable companies.
Share
View Post
  • 5 min

Pharma Marketing Over Decades– Asrar Qureshi’s Blog Post #1079

Asrar Qureshi’s blog discusses the transformation of pharmaceutical marketing, highlighting a shift from sales-driven approaches to patient-centric strategies. While global trends favor digital engagement and direct-to-consumer marketing, Pakistan remains reliant on traditional methods. Greater compliance and ethical engagement are necessary to modernize the industry and meet evolving patient expectations.
Share
View Post
  • 5 min

Customer-centric Approach in Selling – Asrar Qureshi’s Blog Post #1078

Asrar Qureshi’s Blog Post #1078 discusses the need for the pharmaceutical industry to shift from traditional product selling to value-driven, solution-oriented models. Rapid technological advancements and rising customer expectations necessitate a focus on long-term relationships and customer experience rather than mere transactions. Businesses that adapt will thrive in today’s competitive landscape.
Share
View Post
  • 5 min

Is Your Learning & Development Functioning? – Asrar Qureshi’s Blog Post #1030

The blog post emphasizes the importance of Learning and Development (L&D) in pharma companies, arguing that it should align with business strategies and benefit all departments, not just sales. It advocates for creating a strong organizational culture, improving company image, and prioritizing employee capability to support overall corporate goals and ensure long-term growth.
Share